QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
ImmunityBio, Inc.
ImmunityBio, Inc.
Immatics US, Inc.
Acepodia Biotech, Inc.
SCG Cell Therapy Pte. Ltd.
HRYZ Biotech Co.
HRYZ Biotech Co.
Brooklyn ImmunoTherapeutics, LLC
NexImmune Inc.
Fate Therapeutics
Fate Therapeutics
Fate Therapeutics
CEL-SCI Corporation
Genocea Biosciences, Inc.
Corregene Biotechnology Co., Ltd
Gliknik Inc.
Brooklyn ImmunoTherapeutics, LLC